Beta emitters rhenium‐188 and lutetium‐177 are equally effective in radioimmunotherapy of HPV‐positive experimental cervical cancer

Cervical cancer caused by the infection with the human papillomavirus (HPV) remains the fourth leading killer of women worldwide. Therefore, more efficacious treatments are needed. We are developing radioimmunotherapy (RIT) of HPV‐positive cervical cancers by targeting E6 and E7 viral oncoproteins e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Med
Main Authors: Phaeton, Rebecca, Jiang, Zewei, Revskaya, Ekaterina, Fisher, Darrell R., Goldberg, Gary L., Dadachova, Ekaterina
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Clinical Cancer Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708900/
https://ncbi.nlm.nih.gov/pubmed/26625938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.562
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki